ICL secures record loan

Israel Chemicals Ltd. announced on Tuesday that it has secured a $725m. loan from a group of 17 banks, the largest- ever international loan obtained by an Israeli company.

By MATHEW KRIEGER
August 8, 2007 07:54

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Israel Chemicals Ltd. announced on Tuesday that it has secured a $725m. loan from a group of 17 banks, the largest- ever international loan obtained by an Israeli company. According to the agreement, the loan is for a period of five years and will be repaid in full at the end of the period. The loan carries an interest rate of 0.45 percent over the London Interbank Offered Rate and replaces an existing $250m. loan, secured in 2005 at an interest rate of 0.60% over LIBOR, Tel Aviv-based Israel Chemicals said. ICL believes that its success in securing this significant loan at such a low margin, together with the prestige of the large number of international banks participating in the transaction, confirm the strong standing that ICL has achieved in international financial markets

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS